Recensa Therapeutics

Recensa Therapeutics, Inc. has a new approach to treating psoriasis: targeting oxidative stress.

Business Model:

Revenue: $0

Employees: 11-50

Detailed Recensa Therapeutics Information

Geographic Data

Recensa Therapeutics headquarters map

Address:

City: Philadelphia

State: Pennsylvania

Zip:

Country: United States

Financial Info

Stage:

pre seed

Raised Last:

$50k

Raised Total:

$77k

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Recensa is developing small molecules that activate the transcription factor Nrf2, a key modulator of antioxidant response. These molecules will be embedded in topical vehicles-such as creams or lotions-and will be tested in animal models of psoriasis so we can gain FDA approval for human clinical trials. Future products may target other diseases where oxidative stress is a key factor

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
6/2017 Pre Seed Round 1 $50k Phase 1 Ventures
Phase 1 Ventures
6/2016 Pre Seed Round 2 $27k Phase 1 Ventures
Phase One Ventures
Phase 1 Ventures
Phase One Ventures
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research